Our publisher, Steve Freed, had a chance to talk with Dr. Stanley Schwartz, asking questions and getting some in-depth and very informative answers on exactly how SGLT-2 Inhibitors work. Steve Freed: Regarding the SGLT2 drugs that are now available, I know that a lot of physicians just refuse to write …
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #46: Pharmacotherapy of Type 2 Diabetes, Part 5
Richard S. Beaser, MD This week’s excerpt addresses the following topics: What is the "Incretin Effect"? The seven actions of GLP-1 Efficacy of DPP-IV inhibitors Where do the bile acid sequestrants fit in?
Read More »Glimepiride Added to Insulin Regimen May Result in Better Outcomes
Added glimepiride may be better than increasing insulin doses….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #45: Pharmacotherapy of Type 2 Diabetes, Part 4
Richard S. Beaser, MD This week’s excerpt covers the following topics: Which medications slow glucose absorption? Which medications increase insulin secretion? What is first phase insulin response? Who are the patient candidates for the different drug classes? Nateglinide vs. Repaglinide
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #44: Pharmacotherapy of Type 2 Diabetes, Part 3
Richard S. Beaser, MD This week’s excerpt covers the following topics: Which medications reduce insulin resistance The action of biguanides How thiazolidinediones work The risks of thiazolidinediones Liver toxicity with medications
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #43: Pharmacotherapy of Type 2 Diabetes, Part 2
Richard S. Beaser, MD This week’s excerpt covers the following topics: The mechanism of action for antidiabetes medications Which medications improve insulin action Which meds slow gastric absorption Which meds increase insulin secretion Which meds increase the effect of incretins How to compare diabetes meds
Read More »STAMPEDE 3 Results: Bariatric Surgery vs. Intensive Medical Therapy
It appears to offer better and more durable control of diabetes than medical therapy….
Read More »GLP-1 Slows Hypoglycemia
Glucagon-like peptide 1 (GLP-1) slows the accelerated gastric emptying associated with hypoglycemia, according to a crossover study….
Read More »Bariatric Surgery vs. Intensive Medical Therapy for Diabetes
The results of the STAMPEDE Study compares intensive medical management of diabetes to gastric bypass and sleeve gastrectomy….
Read More »GLP-1 Agonist Interaction with Insulin-Induced Hypoglycemia
A study shows GLP-1 agonists slow the acceleration of gastric emptying that occurs as a result of insulin-induced hypoglycemia…. Glucagon-like peptide 1 (GLP-1) receptor agonists are used as monotherapy, secondary therapy with other oral agents, and in combination with basal insulin for management of type 2 diabetes. Though they are …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.